[ad_1] Joe Maher/Getty Images Entertainment Novo Nordisk (NVO) drew the ire of Sen. Bernie Sanders (I-Vt.) following the release of…
Browsing: Novo
[ad_1] Ole Schwander Novo Nordisk (NVO) is reportedly aiming to launch its next-generation obesity drugs Cagrisema and amycretin ahead of…
[ad_1] Ole Schwander Novo Nordisk (NVO) reportedly expects its popular weight-loss drug Wegovy to be approved in China this year,…
[ad_1] Novo Nordisk’s stock hit a fresh record high as the Danish drugmaker held a capital-market day, presenting the next-generation…
[ad_1] Novo Nordisk’s (NVO) blockbuster diabetes drug, Ozempic (semaglutide), reduced the risk of kidney disease progression in a late-stage trial,…
[ad_1] Ole Schwander Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY), manufacturers of two of the most popular weight loss drugs…
[ad_1] Tim de Waele/Velo via Getty Images Novo Nordisk’s (NVO) has granted its CEO Lars Fruergaard Jørgensen a 13% raise…
[ad_1] On Monday, JPMorgan (NYSE:) reaffirmed its Overweight rating on Novo Nordisk (CSE:) (NOVOB:DC) (NYSE: NYSE:), in light of the…
[ad_1] The controlling shareholder of weight-loss drug maker Novo Nordisk on Monday said it’s buying a provider of drug manufacturing…
[ad_1] Novo Holdings has agreed to acquire Catalent, Inc. (NYSE:) for $63.50 per share in a deal valued at $16.5…